A Comparison of Attitudes Toward Pharmacological Treatment Versus Enhancement Under Competitive and Noncompetitive Conditions

AJOB Empirical Bioethics 5 (2):80-90 (2014)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Keywords

Reprint years

DOI

10.1080/23294515.2013.850122

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,202

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Life context of pharmacological academic performance enhancement among university students – a qualitative approach.Elisabeth Hildt, Klaus Lieb & Andreas G. Franke - 2014 - BMC Medical Ethics 15 (1):23.
Punishment, Pharmacological Treatment, and Early Release.Jesper Ryberg - 2012 - International Journal of Applied Philosophy 26 (2):231-244.
The Evaluation of Psychopharmacological Enhancers Beyond a Normative “Natural”–“Artificial” Dichotomy.Jakov Gather - 2011 - Medicine Studies 3 (1):19-27.
Pharmacological cognitive enhancement : how neuroscientific research could advance ethical debate.Hannah Maslen, Nadira Faulmüller & Julian Savulescu - unknown
Reasons for Comfort and Discomfort with Pharmacological Enhancement of Cognitive, Affective, and Social Domains.Laura Y. Cabrera, Nicholas S. Fitz & Peter B. Reiner - 2014 - Neuroethics 8 (2):93-106.
Australian University Students' Attitudes Towards the Acceptability and Regulation of Pharmaceuticals to Improve Academic Performance.Stephanie Bell, Brad Partridge, Jayne Lucke & Wayne Hall - 2012 - Neuroethics 6 (1):197-205.
One Man's Authenticity is Another Man's Betrayal: A Reply to Levy.Alexandre Erler - 2012 - Journal of Applied Philosophy 29 (3):257-265.
The Myth of Cognitive Enhancement Drugs.Hazem Zohny - 2015 - Neuroethics 8 (3):257-269.
Making human better and making better humans.Mairi Levitt & Fiona K. O'Neill - 2010 - Genomics, Society and Policy 6 (1):1-14.
Enhancing Autonomy by Reducing Impulsivity: The Case of ADHD.Jonathan Pugh - 2014 - Neuroethics 7 (3):373-375.
Sobre la relevancia moral de la distinción mejora-tratamiento.Blanca Rodríguez - 2012 - Dilemata 10:307-328.
Moral enhancement and personal autonomy.Lucas Venter - unknown
Normal Human Variation: Refocussing the Enhancement Debate.Guy Kahane & Julian Savulescu - 2013 - Bioethics 29 (2):133-143.
The Dynamics of the Treatment-enhancement Distinction: ADHD as a Case Study.Maartje Schermer - 2007 - Philosophica 79 (1):25-37.
Genetic Enhancement and Parental Obligation.Larry A. Herzberg - 2007 - Philosophy in the Contemporary World 14 (2):98-111.

Analytics

Added to PP
2015-09-04

Downloads
38 (#398,871)

6 months
4 (#698,851)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

Listening to Prozac.Peter D. Kramer - 1994 - Perspectives in Biology and Medicine 37 (3):460.
Cognitive enhancement, cheating, and accomplishment.Rob Goodman - 2010 - Kennedy Institute of Ethics Journal 20 (2):pp. 145-160.
Prozac, Enhancement, and Self‐Creation.David Degrazia - 2000 - Hastings Center Report 30 (2):34-40.
Deflating the Neuroenhancement Bubble.Jayne C. Lucke, Stephanie Bell, Brad Partridge & Wayne D. Hall - 2011 - American Journal of Bioethics Neuroscience 2 (4):38-43.

View all 17 references / Add more references